Nuala Peter

1.2k total citations · 1 hit paper
10 papers, 935 citations indexed

About

Nuala Peter is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nuala Peter has authored 10 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nuala Peter's work include Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Nuala Peter is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Nuala Peter collaborates with scholars based in Germany, United States and Canada. Nuala Peter's co-authors include Jeffrey Friedman, Sam Schulman, Sebastian Schellong, Samuel Z. Goldhaber, Clive Kearon, Henry Eriksson, Ajay K. Kakkar, Florence Le Maulf, Anita Vedel Christiansen and Patrick Mismetti and has published in prestigious journals such as Circulation, Blood and Annals of the Rheumatic Diseases.

In The Last Decade

Nuala Peter

9 papers receiving 911 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

2013 688 citations Sam Schulman, Ajay K. Kakkar et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nuala Peter Germany	8	715	694	153	141	120	10	935
Eugenio Bucherini Italy	14	778 1.1×	538 0.8×	393 2.6×	174 1.2×	32 0.3×	28	960
Susana Meschengieser Argentina	15	273 0.4×	369 0.5×	150 1.0×	393 2.8×	93 0.8×	37	841
Melvin R. Mac Gillavry Netherlands	13	303 0.4×	278 0.4×	58 0.4×	210 1.5×	32 0.3×	21	745
Karlyn A. Martin United States	13	703 1.0×	672 1.0×	170 1.1×	151 1.1×	18 0.1×	39	1.0k
Colin Chesterman Australia	4	735 1.0×	567 0.8×	353 2.3×	204 1.4×	13 0.1×	4	940
Alessandra Malato Italy	18	543 0.8×	384 0.6×	227 1.5×	281 2.0×	105 0.9×	59	940
Johan Elf Sweden	16	400 0.6×	254 0.4×	208 1.4×	112 0.8×	23 0.2×	41	680
Laura M. Faber Netherlands	13	565 0.8×	644 0.9×	116 0.8×	41 0.3×	34 0.3×	35	944
Mikala F. Jarner Netherlands	9	605 0.8×	472 0.7×	188 1.2×	72 0.5×	14 0.1×	10	785
L. Crippa Italy	14	406 0.6×	255 0.4×	221 1.4×	291 2.1×	41 0.3×	24	743

Countries citing papers authored by Nuala Peter

Since Specialization

Citations

This map shows the geographic impact of Nuala Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuala Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuala Peter more than expected).

Fields of papers citing papers by Nuala Peter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuala Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuala Peter. The network helps show where Nuala Peter may publish in the future.

Co-authorship network of co-authors of Nuala Peter

This figure shows the co-authorship network connecting the top 25 collaborators of Nuala Peter. A scholar is included among the top collaborators of Nuala Peter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuala Peter. Nuala Peter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Peter, Nuala, Thierry Danays, Brian Buck, et al.. (2025). Intravenous Tenecteplase Compared With Alteplase for Acute Ischemic Stroke in Canada (AcT): Bridging the Gap From Academia to Regulatory Approval. Stroke Vascular and Interventional Neurology. 5(4). e001705–e001705.

Lytvyn, Yuliya, Karen Kimura, Nuala Peter, et al.. (2022). Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition. Circulation. 146(6). 450–462. 41 indexed citations

Cohen, Stanley, et al.. (2019). Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext). Expert Opinion on Biological Therapy. 19(10). 1097–1105. 21 indexed citations

Cohen, Stanley, A. Alonso-Ruiz, Piotr Adrian Klimiuk, et al.. (2018). Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study. Annals of the Rheumatic Diseases. 77(6). 914–921. 98 indexed citations

Cohen, Stanley, A. Alonso-Ruiz, Piotr Adrian Klimiuk, et al.. (2017). FRI0189 Similar efficacy and safety of biosimilar candidate BI 695501 and adalimumab originator reference product in patients with moderate to severe active rheumatoid arthritis: 24 week results from a phase III clinical study (voltaire®-ra). Annals of the Rheumatic Diseases. 76. 553–553. 6 indexed citations

Schulman, Sam, Samuel Z. Goldhaber, Clive Kearon, et al.. (2013). Influence Of Active Cancer On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II. Blood. 122(21). 582–582. 19 indexed citations

Schulman, Sam, Samuel Z. Goldhaber, Clive Kearon, et al.. (2013). Influence Of Age On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis Of RE-Cover and RE-Cover II. Blood. 122(21). 2375–2375. 13 indexed citations

Schulman, Sam, Henry Eriksson, Samuel Z. Goldhaber, et al.. (2013). Influence Of Concomitant NSAID Or ASA On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II. Blood. 122(21). 1136–1136. 36 indexed citations

Schulman, Sam, Samuel Z. Goldhaber, Clive Kearon, et al.. (2013). Influence Of Renal Function On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II. Blood. 122(21). 212–212. 13 indexed citations

10.

Schulman, Sam, Ajay K. Kakkar, Samuel Z. Goldhaber, et al.. (2013). Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis. Circulation. 129(7). 764–772. 688 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact